Fosinopril/hydroch lorothiazide: Single dose and steady-state pharmacokinetics and pharmacodynamics

British Journal of Clinical Pharmacology

Volumn 48, Issue 3, 1999, Pages 375-381

  O'Grady, Padraig ^a   Yee, Kan Fat ^a   Lins, Robert ^b   Mangold, Bernhard ^a  

^a BRISTOL MYERS SQUIBB   (United States)

^b Stuivenberg General Hospital   (Belgium)

Author keywords

Angiotensin converting enzyme inhibitor; Fosinopril; Fosinoprilat; Hydrochlorothiazide; Pharmacodynamics; Pharmacokinetics; Renal insufficiency

Indexed keywords

CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE; FOSINOPRIL; HYDROCHLOROTHIAZIDE; ANTIHYPERTENSIVE AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ADULT; AGED; AREA UNDER THE CURVE; ARTERIAL PRESSURE; ARTICLE; BODY MASS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE CLEARANCE; DRUG ACCUMULATION; DRUG BLOOD LEVEL; DRUG URINE LEVEL; ENZYME INHIBITION; FATIGUE; FEMALE; HEADACHE; HUMAN; HYPERTENSION; KIDNEY DISEASE; MALE; ORAL DRUG ADMINISTRATION; PHARMACODYNAMICS; PRIORITY JOURNAL; STEADY STATE; URINARY EXCRETION; ADOLESCENT; BLOOD PRESSURE; CASE CONTROL STUDY; DEMOGRAPHY; DRUG EFFECT; DRUG INTERACTION; KIDNEY; KIDNEY FAILURE; METABOLIC CLEARANCE RATE; METABOLISM; MIDDLE AGED;

ADOLESCENT; ADULT; AGED; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; CASE-CONTROL STUDIES; DEMOGRAPHY; DRUG INTERACTIONS; FEMALE; FOSINOPRIL; HUMANS; HYDROCHLOROTHIAZIDE; KIDNEY; KIDNEY FAILURE; MALE; METABOLIC CLEARANCE RATE; MIDDLE AGED;

EID: 0032589346     PISSN: 03065251     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2125.1999.00013.x     Document Type: Article

References (17)

1. Sica DA, Cutler RE, Parmer RJ, Ford NF. Comparison of the steady-state pharmacokinetics of fosinopril, lisinopril and enalapril in patients with chronic renal insufficiency. Clin Pharmacokinet 1991; 20: 420-427.
2. Singhvi SM, Duchin KL, Morrison RA, Willard DA, Everett DW, Frantz M. Disposition of fosinopril sodium in healthy subjects. Br J Clin Pharmacol 1988; 25: 9-15.
3. Hui KK, Duchin KL, Kripalani KJ, Chan D, Kramer PK, Yanagawa N. Pharmacokinetics of fosinopril in patients with various degrees of renal function. Clin Pharmacol Ther 1991; 49: 457-467.
4. Gehr TW, Sica DA, Grasela DM, Fakhry I, Davis J, Duchin KL. Fosinopril pharmacokinetics and pharmacodynamics in chronic ambulatory peritoneal dialysis patients. Eur J Clin Pharmacol 1991; 41: 165-169.
5. Laher MS, Mulkerrins E, Hosic J, Connell PA, Smith RP, Swaisland AJ. The effects of age and renal impairment on the pharmacokinetics of co-administered lisinopril and hydrochlorothiazide. J Human Hypertension 1991; 5(Suppl 2): 77-84.
6. Swaisland AJ. The pharmacokinetics of co-administered lisinopril and hydrochlorothiazide. J Human Hypertension 1991; 5(Suppl 2): 60-71.
7. Hersh AD, Kelly JG, Laher MS, Carmody M, Doyle GD. Effect of hydrochlorothiazide on the pharmacokinetics of enalapril in hypertensive patients with varying renal function. J Cardiovasc Pharmacol 1996; 27: 7-11.
8. Weisser K, Schloos J, Jakob S, Muhlberg W, Platt D, Mutschler E. The influence of hydrochlorothiazide on the pharmacokinetics of enalapril in elderly patients. Eur J Clin Pharmacol 1992; 43: 173-177.
9. Tu J I, Brennan J, Stouffer B, et al. A radioimmunoassay for SQ-27,519, the active phosphonic acid-carboxylic diacid of the pro-drug fosinopril. Ther Drug Monitoring 1990; 12: 404-412.
10. Dvorin D, Whigan D. Automated assay for hydrochlorothiazide in plasma using the Zymark PyTechnology™ Robotic System. Bristol-Myers Squibb Internal ARD report no. CRM3548, December 22 1987.
11. Rohatgi PK, Ryan JW. Simple radioassay for measuring serum activity of angiotensin-converting enzyme in sarcoidosis. Chest 1980; 78: 69-76.
12. StatXact-Turbo User Manual. CYTEL Software Corporation. Cambridge, MA, USA 1992.
13. SAS/STAT User's Guide, sl, 2 Version 6. SAS Institute Incorporated. Gary, NC, USA, Year.
14. Barbhaiya RH, Craig WA, Corrick-West HP, Welling PG. Pharmacokinetics of hydrochlorothiazide in fasted and nonfasted subjects: a comparison of plasma level and urinary excretion methods. J Pharm Sci 1982; 71: 245-248.
15. Beermann B, Groschinsky-Grind M. Pharmacokinetics of hydrochlorothiazide in patients with congestive heart failure. Br J Clin Pharmacol 1979; 7: 579-583.
16. Niemeyer C, Hasenfuss G, Wais U, Knauf H, Schafer-Korting M, Mutschler E. Pharmacokinetics of hydrochlorothiazide in relation to renal function. Eur J Clin Pharmacol 1983; 24: 661-665.
17. Roux A, Le Liboux A, Delhotal B, Gaillot J, Flouvat B. Pharmacokinetics in man of acebutolol and hydrochlorothiazide as single agents and in combination. Eur J Clin Pharmacol 1983; 24: 801 806.